{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T05:54:41Z","timestamp":1771307681944,"version":"3.50.1"},"reference-count":5,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,7]],"date-time":"2024-11-07T00:00:00Z","timestamp":1730937600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,11,7]],"date-time":"2024-11-07T00:00:00Z","timestamp":1730937600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sig Transduct Target Ther"],"DOI":"10.1038\/s41392-024-02026-5","type":"journal-article","created":{"date-parts":[[2024,11,7]],"date-time":"2024-11-07T12:01:59Z","timestamp":1730980919000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Multiplexed RNAs in lipid nanoparticles: potential therapeutic vaccine for chronic hepatitis B"],"prefix":"10.1038","volume":"9","author":[{"given":"Hari Krishnareddy","family":"Rachamala","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2451-3359","authenticated-orcid":false,"given":"Srujan","family":"Marepally","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,11,7]]},"reference":[{"key":"2026_CR1","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1038\/s41392-024-01871-8","volume":"9","author":"W Zai","year":"2024","unstructured":"Zai, W. et al. Optimized RNA interference therapeutics combined with interleukin-2 mRNA for treating hepatitis B virus infection. Signal Transduct. Target Ther. 9, 150 (2024).","journal-title":"Signal Transduct. Target Ther."},{"key":"2026_CR2","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.1038\/s41590-024-01928-4","volume":"25","author":"K Heim","year":"2024","unstructured":"Heim, K. et al. Attenuated effector T cells are linked to control of chronic HBV infection. Nat. Immunol. 25, 1650\u20131662 (2024).","journal-title":"Nat. Immunol."},{"key":"2026_CR3","doi-asserted-by":"publisher","DOI":"10.1038\/s41540-023-00323-3","volume":"9","author":"BA Pfeifer","year":"2023","unstructured":"Pfeifer, B. A., Beitelshees, M., Hill, A., Bassett, J. & Jones, C. H. Harnessing synthetic biology for advancing RNA therapeutics and vaccine design. NPJ Syst. Biol. Appl 9, 60 (2023).","journal-title":"NPJ Syst. Biol. Appl"},{"key":"2026_CR4","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1038\/s41573-024-00943-2","volume":"23","author":"JR Androsavich","year":"2024","unstructured":"Androsavich, J. R. Frameworks for transformational breakthroughs in RNA-based medicines. Nat. Rev. Drug Discov. 23, 421\u2013444 (2024).","journal-title":"Nat. Rev. Drug Discov."},{"key":"2026_CR5","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1158\/2326-6066.CIR-23-0701","volume":"12","author":"D Peters","year":"2024","unstructured":"Peters, D. et al. RNA-encoded interleukin-2 with extended bioavailability amplifies RNA vaccine-induced antitumor T-cell immunity. Cancer Immunol. Res. 12, 1409\u20131420 (2024).","journal-title":"Cancer Immunol. Res."}],"container-title":["Signal Transduction and Targeted Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41392-024-02026-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41392-024-02026-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41392-024-02026-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,7]],"date-time":"2024-11-07T13:08:08Z","timestamp":1730984888000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41392-024-02026-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,7]]},"references-count":5,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["2026"],"URL":"https:\/\/doi.org\/10.1038\/s41392-024-02026-5","relation":{},"ISSN":["2059-3635"],"issn-type":[{"value":"2059-3635","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,7]]},"assertion":[{"value":"14 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 October 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"312"}}